TAK 財務： Takeda Pharmaceutical Company Limited AI 分析



財務狀況

TAK 財務

Takeda Pharmaceutical Company Limited

$15.72

-0.75%

$-0.11

收盤價：Jun 24, 16:00:00 GMT-4

-100%

$-15.72

盤前：Jun 25, 04:15:10 GMT-4

概觀預測收益股利財務狀況

關鍵數據

前收市價

$15.84

開盤價

$15.9

當日範圍

52週區間

交易量

2.9M

平均成交量

3.0M

股息收益率

每股盈餘 (TTM)

0.37

市值

什麼是 Takeda Pharmaceutical Company L？

武田藥品工業株式會社從事藥品的研發、製造、進出口銷售及市場營銷。公司總部位於東京中央區，目前擁有47,455名全職員工。公司主要業務領域包括胃腸疾病、罕見疾病、血漿衍生物（免疫疾病）、腫瘤學（癌症）和神經科學（神經精神疾病）。公司在三個研發領域開展工作：創新型生物製藥，重點針對胃腸和炎症疾病、神經科學以及腫瘤學，此外還包括血漿衍生物和疫苗。大多數藥品用於治療重點疾病領域和血漿衍生物領域的罕見疾病。公司業務遍及日本、美國、歐洲和中國。

功能特性

Markets

News

使用條款隱私權政策

Breakdown	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025
營收	4,505,720	1,094,541	1,191,698	1,112,796	1,106,685	1,053,399
營收年增率 (YoY)	-2%	4%	4%	-5%	-8%	0%
營收成本	1,571,588	405,704	401,148	380,061	384,675	382,078
毛利	2,934,132	688,837	790,550	732,735	722,010	671,321
銷售、一般及管理費用	1,084,215	291,996	282,783	253,551	255,885	295,866
研發	675,924	195,320	175,231	161,482	143,891	216,007
營業費用	2,525,371	702,458	615,971	589,997	535,145	694,989
其他非營業收入 (費用)	--	--	--	-1	1	--
稅前淨利	260,189	-52,479	133,864	28,174	150,630	-107,299
所得稅費用	68,163	-28,222	30,131	39,903	26,351	-4,201
淨利	191,762	-24,319	103,640	-11,802	124,243	-103,155
淨利成長	78%	-76%	336%	-112.99%	30%	3,318%
稀釋後流通股數	1,579.3	1,579.3	1,578.74	1,577.46	1,564.72	1,579.47
股數年變動 (YoY)	0%	0%	0%	-2%	-2%	1%
每股盈餘 (稀釋)	121.42	-15.39	65.64	-7.48	79.4	-65.3
每股盈餘成長率	78%	-76%	337%	-112.99%	32%	3,294%
自由現金流	630,498	11,239	153,501	325,403	140,355	129,435
每股自由現金流	--	--	--	--	--	--
毛利率	65.12%	62.93%	66.33%	65.84%	65.24%	63.72%
營業利益率	9.07%	-1.24%	14.64%	12.82%	16.88%	-2.24%
淨利率	4.25%	-2.22%	8.69%	-1.06%	11.22%	-9.79%
自由現金流利潤率	13.99%	1.02%	12.88%	29.24%	12.68%	12.28%
EBITDA	960,505	141,216	310,735	274,151	316,203	128,143
EBITDA 利潤率	21.31%	12.9%	26.07%	24.63%	28.57%	12.16%
EBITDA 中的折舊與攤銷	551,744	154,837	136,156	131,413	129,338	151,811
EBIT	408,761	-13,621	174,579	142,738	186,865	-23,668
EBIT 利潤率	9.07%	-1.24%	14.64%	12.82%	16.88%	-2.24%
有效稅率	26.19%	53.77%	22.5%	141.63%	17.49%	3.91%

Breakdown

TTM

03/31/2026

12/31/2025

09/30/2025

06/30/2025

03/31/2025

營收

4,505,720

1,094,541

1,191,698

1,112,796

1,106,685

1,053,399

營收年增率 (YoY)

-2%

-5%

-8%

營收成本

1,571,588

405,704

401,148

380,061

384,675

382,078

毛利

2,934,132

688,837

790,550

732,735

722,010

671,321

銷售、一般及管理費用

1,084,215

291,996

282,783

253,551

255,885

295,866

研發

675,924

195,320

175,231

161,482

143,891

216,007

營業費用

2,525,371

702,458

615,971

589,997

535,145

694,989

其他非營業收入 (費用)

-1

稅前淨利

260,189

-52,479

133,864

28,174

150,630

-107,299

所得稅費用

68,163

-28,222

30,131

39,903

26,351

-4,201

淨利

191,762

-24,319

103,640

-11,802

124,243

-103,155

淨利成長

78%

-76%

336%

-112.99%

30%

3,318%

稀釋後流通股數

1,579.3

1,578.74

1,577.46

1,564.72

1,579.47

股數年變動 (YoY)

-2%

每股盈餘 (稀釋)

121.42

-15.39

65.64

-7.48

79.4

-65.3

每股盈餘成長率

78%

-76%

337%

-112.99%

32%

3,294%

自由現金流

630,498

11,239

153,501

325,403

140,355

129,435

每股自由現金流

毛利率

65.12%

62.93%

66.33%

65.84%

65.24%

63.72%

營業利益率

9.07%

-1.24%

14.64%

12.82%

16.88%

-2.24%

淨利率

4.25%

-2.22%

8.69%

-1.06%

11.22%

-9.79%

自由現金流利潤率

13.99%

1.02%

12.88%

29.24%

12.68%

12.28%

EBITDA

960,505

141,216

310,735

274,151

316,203

128,143

EBITDA 利潤率

21.31%

12.9%

26.07%

24.63%

28.57%

12.16%

EBITDA 中的折舊與攤銷

551,744

154,837

136,156

131,413

129,338

151,811

EBIT

408,761

-13,621

174,579

142,738

186,865

-23,668

EBIT 利潤率

9.07%

-1.24%

14.64%

12.82%

16.88%

-2.24%

有效稅率

26.19%

53.77%

22.5%

141.63%

17.49%

3.91%

Follow-Up Questions

Takeda Pharmaceutical Company Limited의 주요 재무제표는 무엇인가요?



최신 재무제표(Form-10K)에 따르면, Takeda Pharmaceutical Company Limited의 총 자산은 $0이며, 순損失입니다.

TAK의 주요 재무 비율은 무엇인가요?



Takeda Pharmaceutical Company Limited의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.

Takeda Pharmaceutical Company Limited의 매출은 부문 또는 지역별로 어떻게 나뉘나요?



Takeda Pharmaceutical Company Limited 最大收入來源為 Gastroenterology Revenue (Pre-FY2023 Reporting)，在最近的收益報告中收入為 1,216,207,000,000。就地區而言，Japan 是 Takeda Pharmaceutical Company Limited 的主要市場，收入為 418,462,000,000。

Takeda Pharmaceutical Company Limited은 수익성이 있나요?



無, 최신 재무제표에 따르면 Takeda Pharmaceutical Company Limited의 순損失은 $0입니다.

Takeda Pharmaceutical Company Limited에 부채가 있나요?



無, Takeda Pharmaceutical Company Limited의 부채는 0입니다.

Takeda Pharmaceutical Company Limited의 발행 주식은 몇 주인가요?



Takeda Pharmaceutical Company Limited의 총 발행 주식은 0주입니다.

Takeda Pharmaceutical Company Limited (TAK) 財務

TAK 股價走勢圖

關鍵數據

前收市價

開盤價

當日範圍

52週區間

交易量

平均成交量

股息收益率

每股盈餘 (TTM)

市值

什麼是 Takeda Pharmaceutical Company L？

Takeda Pharmaceutical Company Limited (TAK) 財務

TAK 股價走勢圖

關鍵數據

前收市價

開盤價

當日範圍

52週區間

交易量

平均成交量

股息收益率

每股盈餘 (TTM)

市值

什麼是 Takeda Pharmaceutical Company L？

TAK 收入

Follow-Up Questions

Takeda Pharmaceutical Company Limited의 주요 재무제표는 무엇인가요?

TAK의 주요 재무 비율은 무엇인가요?

Takeda Pharmaceutical Company Limited의 매출은 부문 또는 지역별로 어떻게 나뉘나요?

Takeda Pharmaceutical Company Limited은 수익성이 있나요?

Takeda Pharmaceutical Company Limited에 부채가 있나요?

Takeda Pharmaceutical Company Limited의 발행 주식은 몇 주인가요?